TGTX
Tg Therapeutics Inc
NASDAQ · Biotechnology
$28.86
+1.10 (+3.96%)
Performance
1D
—
1W
-1.10%
1M
+4.11%
3M
-7.23%
6M
+3.55%
1Y
-10.51%
YTD
-1.43%
Open$28.25
Previous Close$27.76
Day High$28.95
Day Low$27.83
52W High$46.48
52W Low$25.28
Volume1.62M
Avg Volume1.59M
Market Cap4.58B
P/E Ratio10.24
EPS$2.78
SectorBiotechnology
Volume Analysis
1.02x average volume
Technical Indicators
SMA 50
$30.49
Below
SMA 200
$33.44
Below
RSI (14)
38.4
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+116.2% upside
Current
$28.86
$28.86
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 325.77M | 1.04B | 1.08B |
| Net Income | 23.15M | 129.57M | 136.18M |
| Profit Margin | 7.1% | 12.5% | 12.7% |
| EBITDA | 49.20M | 169.61M | 170.48M |
| Free Cash Flow | — | 110.01M | 140.89M |
| Rev Growth | +266.4% | +16.6% | +24.3% |
| Debt/Equity | 1.10 | 0.33 | 0.32 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |